|1 Table of Contents
|1 Table of Contents 3
|1.1 List of Tables 13
|1.2 List of Figures 14
2 Introduction 17
2.1 What Is This Report About? 17
2.2 Neurology Devices Market Segmentation 17
2.3 Definitions of Markets Covered in the Report 19
3 Neurology Devices Market, United States 26
3.1 Neurology Devices Market, United States, Revenue ($m), 2018-2033 26
3.2 Neurology Devices Market, United States, Revenue Mix ($m), 2023 28
3.3 Neurology Devices Market, United States, Category Contribution by Revenue ($m), 2023 29
3.4 Neurology Devices Market, United States, Revenue ($m), 2018-2033 31
3.5 Neurology Devices Market, United States, Volume (Units), 2018-2033 33
3.6 Neurology Devices Market, United States, Volume (Units), 2018-2033 35
3.7 Neurology Devices Market, United States, Company Share by Revenue ($m), 2023 38
4 Hydrocephalus Shunts Market, United States 40
4.1 Hydrocephalus Shunts Market, United States, Revenue Mix ($m), 2023 40
4.2 Hydrocephalus Shunts Market, United States, Segment Contribution (%), 2023 41
4.3 Hydrocephalus Shunts Market, United States, Revenue ($m), 2018-2033 43
4.3.1 Hydrocephalus Catheters Market, United States, Revenue ($m), by Segment, 2018-2033 45
4.3.2 Hydrocephalus Valves Market, United States, Revenue ($m), by Segment, 2018-2033 47
4.4 Hydrocephalus Shunts Market, United States, Volume (Units), 2018-2033 49
4.4.1 Hydrocephalus Catheters Market, United States, Volume (Units), by Segment, 2018-2033 51
4.4.2 Hydrocephalus Valves Market, United States, Volume (Units), by Segment, 2018-2033 53
4.5 Hydrocephalus Shunts Market, United States, Average Price ($), 2018-2033 55
4.6 Hydrocephalus Shunts Market, United States, Distribution Share by Revenue ($m), 2023 56
4.7 Hydrocephalus Shunts Market, United States, Company Share by Revenue ($m), 2023 57
5 Interventional Neuroradiology Market, United States 59
5.1 Interventional Neuroradiology Market, United States, Revenue Mix ($m), 2023 59
5.2 Interventional Neuroradiology Market, United States, Segment Contribution (%), 2023 60
5.3 Interventional Neuroradiology Market, United States, Revenue ($m), 2018-2033 62
5.3.1 Neurovascular Accessory Devices Market, United States, Revenue ($m), by Segment, 2018-2033 64
5.3.2 Neurovascular Coiling Assist Devices Market, United States, Revenue ($m), by Segment, 2018-2033 66
5.3.3 Neurovascular Embolization Devices Market, United States, Revenue ($m), by Segment, 2018-2033 68
5.3.4 Neurovascular Thrombectomy Devices Market, United States, Revenue ($m), by Segment, 2018-2033 70
5.4 Interventional Neuroradiology Market, United States, Volume (Units), 2018-2033 72
5.4.1 Neurovascular Accessory Devices Market, United States, Volume (Units), by Segment, 2018-2033 74
5.4.2 Neurovascular Coiling Assist Devices Market, United States, Volume (Units), by Segment, 2018-2033 76
5.4.3 Neurovascular Embolization Devices Market, United States, Volume (Units), by Segment, 2018-2033 78
5.4.4 Neurovascular Thrombectomy Devices Market, United States, Volume (Units), by Segment, 2018-2033 80
5.5 Interventional Neuroradiology Market, United States, Average Price ($), 2018-2033 82
5.6 Interventional Neuroradiology Market, United States, Distribution Share by Revenue ($m), 2023 84
5.7 Interventional Neuroradiology Market, United States, Company Share by Revenue ($m), 2023 85
6 Minimally Invasive Neurosurgery Market, United States 87
6.1 Minimally Invasive Neurosurgery Market, United States, Revenue Mix ($m), 2023 87
6.2 Minimally Invasive Neurosurgery Market, United States, Segment Contribution (%), 2023 88
6.3 Minimally Invasive Neurosurgery Market, United States, Revenue ($m), 2018-2033 90
6.3.1 Minimally Invasive Neurosurgical Devices Market, United States, Revenue ($m), by Segment, 2018-2033 92
6.4 Minimally Invasive Neurosurgery Market, United States, Volume (Units), 2018-2033 94
6.4.1 Minimally Invasive Neurosurgical Devices Market, United States, Volume (Units), by Segment, 2018-2033 96
6.5 Minimally Invasive Neurosurgery Market, United States, Average Price ($), 2018-2033 98
6.6 Minimally Invasive Neurosurgery Market, United States, Distribution Share by Revenue ($m), 2023 99
6.7 Minimally Invasive Neurosurgery Market, United States, Company Share by Revenue ($m), 2023 100
7 Neurological Diagnostic and Monitoring Equipment Market, United States 102
7.1 Neurological Diagnostic and Monitoring Equipment Market, United States, Revenue Mix ($m), 2023 102
7.2 Neurological Diagnostic and Monitoring Equipment Market, United States, Segment Contribution (%), 2023 103
7.3 Neurological Diagnostic and Monitoring Equipment Market, United States, Revenue ($m), 2018-2033 105
7.3.1 Electrical Activity Testing Market, United States, Revenue ($m), by Segment, 2018-2033 107
7.3.2 ICP Monitoring Devices Market, United States, Revenue ($m), by Segment, 2018-2033 109
7.4 Neurological Diagnostic and Monitoring Equipment Market, United States, Volume (Units), 2018-2033 111
7.4.1 Electrical Activity Testing Market, United States, Volume (Units), by Segment, 2018-2033 113
7.4.2 ICP Monitoring Devices Market, United States, Volume (Units), by Segment, 2018-2033 115
7.5 Neurological Diagnostic and Monitoring Equipment Market, United States, Average Price ($), 2018-2033 117
7.6 Neurological Diagnostic and Monitoring Equipment Market, United States, Distribution Share by Revenue ($m), 2023 118
7.7 Neurological Diagnostic and Monitoring Equipment Market, United States, Company Share by Revenue ($m), 2023 119
8 Neuromodulation Devices Market, United States 121
8.1 Neuromodulation Devices Market, United States, Revenue Mix ($m), 2023 121
8.2 Neuromodulation Devices Market, United States, Segment Contribution (%), 2023 122
8.3 Neuromodulation Devices Market, United States, Revenue ($m), 2018-2033 124
8.3.1 Deep Brain Stimulators (DBS) Market, United States, Revenue ($m), by Segment, 2018-2033 126
8.3.2 Gastric Electric Stimulators (GES) Market, United States, Revenue ($m), by Segment, 2018-2033 128
8.3.3 Peripheral Nerve Stimulators (PNS) Market, United States, Revenue ($m), by Segment, 2018-2033 130
8.3.4 Sacral Nerve Stimulators (SNS) Market, United States, Revenue ($m), by Segment, 2018-2033 132
8.3.5 Spinal Cord Stimulators (SCS) Market, United States, Revenue ($m), by Segment, 2018-2033 134
8.3.6 Vagus Nerve Stimulators (VNS) Market, United States, Revenue ($m), by Segment, 2018-2033 136
8.4 Neuromodulation Devices Market, United States, Volume (Units), 2018-2033 138
8.4.1 Deep Brain Stimulators (DBS) Market, United States, Volume (Units), by Segment, 2018-2033 141
8.4.2 Gastric Electric Stimulators (GES) Market, United States, Volume (Units), by Segment, 2018-2033 143
8.4.3 Peripheral Nerve Stimulators (PNS) Market, United States, Volume (Units), by Segment, 2018-2033 145
8.4.4 Sacral Nerve Stimulators (SNS) Market, United States, Volume (Units), by Segment, 2018-2033 147
8.4.5 Spinal Cord Stimulators (SCS) Market, United States, Volume (Units), by Segment, 2018-2033 149
8.4.6 Vagus Nerve Stimulators (VNS) Market, United States, Volume (Units), by Segment, 2018-2033 151
8.5 Neuromodulation Devices Market, United States, Average Price ($), 2018-2033 153
8.6 Neuromodulation Devices Market, United States, Distribution Share by Revenue ($m), 2023 156
8.7 Neuromodulation Devices Market, United States, Company Share by Revenue ($m), 2023 157
9 Neurosurgical Products Market, United States 159
9.1 Neurosurgical Products Market, United States, Revenue Mix ($m), 2023 159
9.2 Neurosurgical Products Market, United States, Segment Contribution (%), 2023 160
9.3 Neurosurgical Products Market, United States, Revenue ($m), 2018-2033 162
9.3.1 Dura Substitutes Market, United States, Revenue ($m), by Segment, 2018-2033 164
9.3.2 Neuroendoscopes Market, United States, Revenue ($m), by Segment, 2018-2033 166
9.3.3 Neurosurgical Drills Market, United States, Revenue ($m), by Segment, 2018-2033 168
9.4 Neurosurgical Products Market, United States, Volume (Units), 2018-2033 170
9.4.1 Dura Substitutes Market, United States, Volume (Units), by Segment, 2018-2033 172
9.4.2 Neuroendoscopes Market, United States, Volume (Units), by Segment, 2018-2033 174
9.4.3 Neurosurgical Drills Market, United States, Volume (Units), by Segment, 2018-2033 176
9.5 Neurosurgical Products Market, United States, Average Price ($), 2018-2033 178
9.6 Neurosurgical Products Market, United States, Distribution Share by Revenue ($m), 2023 180
9.7 Neurosurgical Products Market, United States, Company Share by Revenue ($m), 2023 181
10 Radiosurgery Systems Market, United States 183
10.1 Radiosurgery Systems Market, United States, Revenue Mix ($m), 2023 183
10.2 Radiosurgery Systems Market, United States, Segment Contribution (%), 2023 184
10.3 Radiosurgery Systems Market, United States, Revenue ($m), 2018-2033 186
10.4 Radiosurgery Systems Market, United States, Volume (Units), 2018-2033 188
10.5 Radiosurgery Systems Market, United States, Average Price ($), 2018-2033 190
10.6 Radiosurgery Systems Market, United States, Distribution Share by Revenue ($m), 2023 191
10.7 Radiosurgery Systems Market, United States, Company Share by Revenue ($m), 2023 192
11 Overview of Key Companies in United States, Neurology Devices Market 194
11.1 Medtronic Plc 194
11.1.1 Company Overview 194
11.2 Boston Scientific Corp 194
11.2.1 Company Overview 194
11.3 Abbott Laboratories 194
11.3.1 Company Overview 194
11.4 Integra LifeSciences Corp 194
11.4.1 Company Overview 194
11.5 Stryker Corp 195
11.5.1 Company Overview 195
11.6 Elekta AB 195
11.6.1 Company Overview 195
11.7 Natus Medical Inc 195
11.7.1 Company Overview 195
11.8 B. Braun Melsungen AG 195
11.8.1 Company Overview 195
11.9 Accuray Inc 196
11.9.1 Company Overview 196
11.10 Penumbra Inc 196
11.10.1 Company Overview 196
11.11 Nihon Kohden Corp 196
11.11.1 Company Overview 196
11.12 Terumo Neuro 196
11.12.1 Company Overview 196
11.13 KARL STORZ SE & Co KG 197
11.13.1 Company Overview 197
11.14 Varian Medical Systems Inc 197
11.14.1 Company Overview 197
11.15 LivaNova Plc 197
11.15.1 Company Overview 197
11.16 Nevro Corp 197
11.16.1 Company Overview 197
11.17 NICO Corporation 198
11.17.1 Company Overview 198
12 Neurology Devices Market Pipeline Products 199
13 Financial Deals Landscape 210
13.1 Acquisition 210
13.1.1 Stryker Acquires NICO 210
13.1.2 DuPont de Nemours Acquires Donatelle Plastics 211
13.1.3 Boston Scientific Acquires Silk Road Medical for USD1.18 Billion 213
13.1.4 Virtual Therapeutics Acquires Akili for USD34.16 Million 215
13.1.5 Adriana Munoz Acquires Admar Diagnostic Instruments (Admar Neurodiagnostic) 217
13.2 Asset Transactions 218
13.2.1 ReShape Lifesciences to Sell Assets to Biorad Medisys for USD5.16 Million 218
13.3 Debt Offerings 220
13.3.1 Stryker Raises USD883.83 Million Public Offering of
3.375% Notes Due 2032 220
13.3.2 Stryker Raises USD662.87 Million in Public Offering of
3.625% Notes Due 2036 221
14 Recent Developments 222
15 Appendix 222